Dr. Sunny Chapel is a co-founder of A2PG, where she provides consulting and hands-on pharmacometrics services. She received her BS in pharmacy from Seoul National University in Korea and her Ph.D. from University of Iowa under Professor Veng-Pedersen's supervision as well as her MS degree in statistics. After graduation, she held positions at Aventis, Amgen, and Pfizer for clinical pharmacology and pharmacokinetics. Her research interests include model-based drug development, especially clinically relevant application of modeling and simulations for quantitative strategic decision making.